Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers

Kiran Shekar, Jenelle Badulak, Giles Peek, Udo Boeken, Heidi J Dalton, Lovkesh Arora, Bishoy Zakhary, Kollengode Ramanathan, Joanne Starr, Bindu Akkanti, M Velia Antonini, Mark T Ogino, Lakshmi Raman*, Nicholas Barret, Daniel Brodie, Alain Combes, Roberto Lorusso, Graeme MacLaren, Thomas Müller, Matthew PadenVincent Pellegrino, ELSO Guideline Working Group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Disclaimer: The Extracorporeal Life Support Organization (ELSO) Coronavirus Disease 2019 (COVID-19) Guidelines have been developed to assist existing extracorporeal membrane oxygenation (ECMO) centers to prepare and plan provision of ECMO during the ongoing pandemic. The recommendations have been put together by a team of interdisciplinary ECMO providers from around the world. Recommendations are based on available evidence, existing best practice guidelines, ethical principles, and expert opinion. This is a living document and will be regularly updated when new information becomes available. ELSO is not liable for the accuracy or completeness of the information in this document. These guidelines are not meant to replace sound clinical judgment or specialist consultation but rather to strengthen provision and clinical management of ECMO specifically, in the context of the COVID-19 pandemic.

Original languageEnglish
Pages (from-to)707-721
Number of pages15
JournalAsaio Journal
Volume66
Issue number7
DOIs
Publication statusPublished - Jul 2020

Keywords

  • ACUTE RESPIRATORY-FAILURE
  • ADULTS
  • Betacoronavirus
  • COVID-19
  • CRITICALLY-ILL PATIENTS
  • Consensus
  • Coronavirus Infections/therapy
  • ECMO
  • Extracorporeal Membrane Oxygenation
  • Humans
  • INFECTION
  • MANAGEMENT
  • OUTCOMES
  • PNEUMONIA
  • POSITION PAPER
  • PREDICTING SURVIVAL
  • PROGRAMS
  • Pandemics
  • Pneumonia, Viral/therapy
  • Practice Guidelines as Topic
  • SARS-CoV-2

Cite this